Results 341 to 350 of about 62,173 (364)

Haploidentical Transplants for Myeloproliferative Neoplasms

2017
Allogeneic hematopoietic cell transplantation remains the only curative therapy available for patients with myeloproliferative neoplasms and is mostly performed for primary myelofibrosis or secondary myelofibrosis with high dynamic international scoring system-plus score, advanced (or refractory) chronic myelogenous leukemia, and chronic myelomonocytic
Richard E. Champlin, Monzr M. Al Malki, Stefan O. Ciurea   +2 more
openaire   +2 more sources

Malignant Neoplasms Occurring After Cardiac Transplantation

JAMA: The Journal of the American Medical Association, 1983
Fifty-seven cardiac transplants in 53 patients have been performed; 30 survived for at least three months. Malignant neoplasms developed in three (10%) of these patients. This incidence is more than double that in recipients of donor kidneys at our institution. Kaposi's sarcoma developed in three patients in the combined groups and accounted for 30% of
Robert Lanza, Michael J. D. Cassidy, David K. C. Cooper, Christiaan N. Barnard   +3 more
openaire   +3 more sources

Liver transplantation in malignant primary hepatic neoplasms

The American Journal of Surgery, 1992
Between April 1986 and August 1990, 151 liver transplantations were performed at our institution, 16 (11%) of them in 14 patients with primary hepatic tumors. There were 12 hepatocellular carcinomas, 1 angiosarcoma, and 1 Klatskin tumor. None of the tumors was resectable, and there was no preoperative evidence of extrahepatic tumoral extension ...
Juan Carlos Palomo, Ignacio Gonzalez-Pinto, Enrique Moreno González, Julio Bercedo, Javier Ibañez, Marcus Sciadini, V. Maffettone, Ramon Gámez, P. Vorwald, Cesar Cisneros, Francisco Pérez Cerda, Damaso Riaño, Pedro Dávila, Fermin Palma, Carmelo Loinaz, I. Garcia   +15 more
openaire   +3 more sources

Cutaneous Malignant Neoplasms in Patients With Renal Transplants [PDF]

Archives of Dermatology, 1986
• There is an increased risk of developing cutaneous neoplasms in patients with renal transplants who are receiving immunosuppressive therapy. We studied 523 consecutive white patients who had received renal transplants at a Canadian medical center. Malignant neoplasms developed in 7.5% of these patients, and 72% of these neoplasms were cutaneous in ...
Carl J. Cardella, Herbert F. Haberman, Aditya K. Gupta   +2 more
openaire   +1 more source

Transplantation of Dog Neoplasms into the Mouse Mutant Nude

Research in Veterinary Science, 1974
Canine osteosarcoma and melanoma cell cultures, fresh canine cells obtained directly from a mammary carcinoma and from a transmissible venereal tumour have been successfully transplanted subcutaneously into Nude mice. The histological appearance of the osteosarcoma in mice resembled that seen when these cell cultures are transplanted in ...
L.N. Owen, S.M.J. Oughton
openaire   +3 more sources

Colorectal and anal neoplasms following liver transplantation

Colorectal Disease, 2010
AbstractObjective  Liver transplantation (LT) is the treatment of choice for end‐stage liver disease. The required immunosuppression increases the risk for developing malignancies. Some viruses play a crucial role. Data on neoplasms of the colon, rectum and anus in LT are limited.Method  A retrospective evaluation of the incidence and clinical course ...
Rolland C. Dickson, C. Jean-Pierre, John A. Stauffer, Ronald A. Hinder, Hugo Bonatti, Hugo Bonatti, Heidi K. Chua, Jeffrey B. Albright, Justin H. Nguyen, Jeffrey L. Steers, Denise M. Harnois, J. Aranda-Michel   +11 more
openaire   +3 more sources

Autologous Islet Transplantation in Patients Requiring Pancreatectomy for Neoplasm

Current Diabetes Reports, 2014
Autologous islet cell transplantation is a procedure performed to prevent or reduce the severity of diabetes after pancreatic resection. Autologous islet cell transplantation is being used almost exclusively in patients undergoing pancreatectomy because of painful, chronic pancreatitis, or multiple recurrent episodes of pancreatitis that is not ...
Balzano, Gianpaolo, PIEMONTI, LORENZO
openaire   +2 more sources

Epidemiologic critique of literature on post‐transplant neoplasms in solid organ transplantation

Clinical Transplantation, 2009
Abstract:  As survival of transplant recipients improves, long‐term complications become more important. We reviewed epidemiologic literature on real‐world risks of de novo neoplasia post‐transplant. We searched the Medline/PubMed, Cochrane, and Embase databases for population‐based studies on risk of neoplasia from 1998 to 2005.
William Irish, Lili Wang, Teresa A. Simon, Lee L. Lanza   +3 more
openaire   +3 more sources

Effect of Sex Hormones on Transplanted Neoplasms

The American Journal of Cancer, 1936
Introduction In 1931 Bischoff and Maxwell (1) tested the effects of prolan, estrin, and placental and pituitary gonadotropic extracts upon the rate of growth of the R10 tumor, administering physiologically standardized amounts. The results were entirely negative.2 The following year, Zondek, Zondek, and Hartoch (2) showed that excessive doses of ...
L. C. Maxwell, Fritz Bischoff
openaire   +2 more sources

Transplantable Mouse Neoplasm Control by Neutron Capture Therapy

Nature, 1967
AFTER several years of effort based on the application of the principles of neutron capture therapy, we have empirically evolved a procedure which now can be added to the few effective treatments for established invasive transplantable neoplasms of animals.
T. Konikowski, Lee E. Farr
openaire   +3 more sources